Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Annali Di Igiene : Medicina Preventiva E Di Comunita|December 10, 2014
[Improving vaccination measures]S Iannazzo
Journal of Preventive Medicine and Hygiene|June 30, 2011
Pharmacoeconomic evaluation of the MF59--adjuvanted influenza vaccine in the elderly population in ItalyS Iannazzo
Annali Di Igiene : Medicina Preventiva E Di Comunita|February 19, 2004
[Comparison between different methods to monitor the microbial level of indoor air contamination in the dental office]S Petti, S Iannazzo, G Tarsitani
Current Medical Research and Opinion|November 21, 2007
Economic evaluation of treatment with orlistat in Italian obese patientsS Iannazzo, O Zaniolo, L Pradelli
Annali Di Igiene : Medicina Preventiva E Di Comunita|February 22, 2018
Immunisation Registries at regional level in Italy and the roadmap for a future Italian National RegistryF D'Ancona, V Gianfredi, F Riccardo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in ItalyS Iannazzo, L Pradelli, M Carsi, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 19, 2010
Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in ItalyO Zaniolo, S Iannazzo, L Pradelli, et al.
Clinical and Experimental Rheumatology|October 2, 2010
Rituximab in the treatment of rheumatoid arthritis patients in Italy: a budget impact analysisM Benucci, S Iannazzo, O Zaniolo, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|August 1, 2018
Childhood vaccine coverage in Italy after the new law on mandatory immunizationC Signorelli, A Odone, P Cella, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 30, 2007
Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patientsNegro Roberto Dal, M Eandi, L Pradelli, et al.
Pageof 3